Atrial pathology in cardiac amyloidosis: evidence from ECG and cardiovascular magnetic resonance.
نویسندگان
چکیده
Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003;290:2292–2300. 14. Di Mario C, Gorge G, Peters R, Kearney P, Pinto F, Hausmann D, von Birgelen C, Colombo A, Mudra H, Roelandt J, Erbel R. Clinical application and image interpretation in intracoronary ultrasound. Study Group on Intracoronary Imaging of the Working Group of Coronary Circulation and of the Subgroup on Intravascular Ultrasound of the Working Group of Echocardiography of the European Society of Cardiology. Eur Heart J 1998;19:207–229. 15. Birnbaum Y, Fishbein MC, Luo H, Nishioka T, Siegel RJ. Regional remodeling of atherosclerotic arteries: a major determinant of clinical manifestations of disease. J Am Coll Cardiol 1997;30:1149–1164. 16. Lim TT, Liang DH, Botas J, Schroeder JS, Oesterle SN, Yeung AC. Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study. Circulation 1997;95:855–859. 17. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 2002;105:297–303. 18. Taylor AJ, Burke AP, Farb A, Yousefi P, Malcom GT, Smialek J, Virmani R. Arterial remodeling in the left coronary system: the role of high-density lipoprotein cholesterol. J Am Coll Cardiol 1999;34:760–767. 19. Clarkson TB, Prichard RW, Morgan TM, Petrick GS, Klein KP. Remodeling of coronary arteries in human and nonhuman primates. JAMA 1994;271:289–294. 20. Gussenhoven EJ, Geselschap JH, van Lankeren W, Posthuma DJ, van der Lugt A. Remodeling of atherosclerotic coronary arteries assessed with intravascular ultrasound in vitro. Am J Cardiol 1997; 79:699–702. 21. Hamasaki S, Higano ST, Suwaidi JA, Nishimura RA, Miyauchi K, Holmes DR Jr, Lerman A. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol 2000;20:737–743.
منابع مشابه
Regression of cardiac amyloidosis after stem cell transplantation assessed by cardiovascular magnetic resonance imaging.
A previously fit 52-year-old man presented with severe progressive exertional dyspnea. He was in heart-failure with an elevated jugular-venous-pressure, edema, and increased plasma-NTpro-BNP levels of 4285 μg/mL (upper limit of normal <900 μg/mL). His ECG demonstrated sinus-rhythm with low limb and chest lead voltages (Figure 1). He had significant proteinuria with renal and bone marrow biopsie...
متن کاملClinical Diagnosis of Electrical Versus Anatomic Left Ventricular Hypertrophy
Left ventricular hypertrophy (LVH) can develop in association with chronic arterial hypertension and other cardiovascular disorders and is a well-established risk factor for cardiac arrhythmias, cardiovascular events, and mortality. Over 4 decades ago the Framingham Heart Study reported that electrocardiographic evidence of LVH (ECG LVH) was associated with 3to 4-fold increase in cardiovascular...
متن کاملQuantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
BACKGROUND Cardiac involvement predicts outcome in systemic AL amyloidosis and influences therapeutic options. Current methods of cardiac assessment do not quantify myocardial amyloid burden. We used equilibrium contrast cardiovascular magnetic resonance (EQ-CMR) to quantify the cardiac interstitial compartment, measured as myocardial extracellular volume (ECV) fraction, hypothesizing it would ...
متن کاملClinical Diagnosis of Electrical Versus Anatomic Left Ventricular Hypertrophy: Prognostic and Therapeutic Implications.
Left ventricular hypertrophy (LVH) can develop in association with chronic arterial hypertension and other cardiovascular disorders and is a well-established risk factor for cardiac arrhythmias, cardiovascular events, and mortality. Over 4 decades ago the Framingham Heart Study reported that electrocardiographic evidence of LVH (ECG LVH) was associated with 3to 4-fold increase in cardiovascular...
متن کاملMagnetic resonance imaging in cardiac amyloidosis.
The amyloidoses are a group of uncommon systemic diseases characterized by the extracellular deposition of pathologic insoluble amyloid protein in organs and tissues. The are 4 main types of amyloidosis: primary (AL, the most prevalent type), familial, secondary, and senile. Each of them has its own physiopathology, distinctive features, and variable cardiac involvement. The symptoms of cardiac...
متن کاملCardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis
BACKGROUND Cardiac involvement is common in amyloidosis and associated with a variably adverse outcome. We have previously shown that cardiovascular magnetic resonance (CMR) can assess deposition of amyloid protein in the myocardial interstitium. In this study we assessed the prognostic value of late gadolinium enhancement (LGE) and gadolinium kinetics in cardiac amyloidosis in a prospective lo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European heart journal
دوره 27 14 شماره
صفحات -
تاریخ انتشار 2006